WUXI, China, Feb. 26, 2025 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization ...
Wuxi. I was both excited, and a little daunted at the prospect. I had never been to China, I didn't speak any Chinese, and I really had no idea what to expect. However, my wife is Chinese ...
Industry-leading development and manufacturing capabilities (Best ADC CDMO in Asia & China): WuXi XDC's state-of-the-art facilities and global dual-sourcing strategy enable seamless CMC ...
EffiXâ„¢ is designed to meet the industry's demand for a high-yield, stable, and non-lysogenic E. coli expression system. It serves as a comprehensive solution for the development and manufacturing of n ...
China’s telecom giants surge on NYSE reversal, WuXi slides as insider sells Hong Kong and China stocks gained as Chinese telecom giants surged after the New York Stock Exchange scraps its ...
Recognized as a leader in Green CRDMO, driving innovation for a healthier future SHANGHAI, Feb. 18, 2025 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research ...
WUXI, China, Feb. 27, 2025 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced that it has ...
EffiXTM is designed to meet the industry's demand for a high-yield, stable, and non-lysogenic E. coli expression system. It serves as a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback